HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

AbstractINTRODUCTION:
Ovarian cancer (OvCa) is among the most common types of cancer and is the leading cause of death from gynecological malignancies in western countries. Cancer biomarkers have a potential for improving the management of OvCa patients at every point from screening and detection, diagnosis, prognosis, follow up, response to therapy and outcome.
AREAS COVERED:
The literature search has indicated a number of candidate biomarkers have recently emerged that could facilitate the molecular definition of OvCa, providing information about prognosis and predicting response to therapy. These potentially promising biomarkers include immune cells and their products, tumor-derived exosomes, nucleic acids and epigenetic biomarkers. Expert commentary: Although most of the biomarkers available today require prospective validation, the development of noninvasive liquid biopsy-based monitoring promises to improve their utility for evaluations of prognosis, response to therapy and outcome in OvCa.
AuthorsMarta Szajnik, Małgorzata Czystowska-Kuźmicz, Esther Elishaev, Theresa L Whiteside
JournalExpert review of molecular diagnostics (Expert Rev Mol Diagn) Vol. 16 Issue 8 Pg. 811-26 (08 2016) ISSN: 1744-8352 [Electronic] England
PMID27268121 (Publication Type: Journal Article, Review)
Chemical References
  • Biomarkers, Tumor
  • CA-125 Antigen
  • MUC16 protein, human
  • Membrane Proteins
  • MicroRNAs
  • Proteins
  • WAP Four-Disulfide Core Domain Protein 2
  • WFDC2 protein, human
Topics
  • Biomarkers, Tumor
  • CA-125 Antigen (blood)
  • Carcinoma (diagnosis, metabolism, mortality, therapy)
  • Combined Modality Therapy
  • Epigenesis, Genetic
  • Exosomes (metabolism)
  • Female
  • Humans
  • Membrane Proteins (blood)
  • MicroRNAs (blood, genetics)
  • Neoplastic Stem Cells (metabolism)
  • Ovarian Neoplasms (diagnosis, metabolism, mortality, therapy)
  • Prognosis
  • Proteins (metabolism)
  • Treatment Outcome
  • WAP Four-Disulfide Core Domain Protein 2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: